-
Mashup Score: 140Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer - 2 month(s) ago
Oncogene – Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
We grossly underestimate how quickly #immunotherapy can work. Especially with BOT/BAL (botensilimab) in our NEST🪺trial we are seeing💡#ctDNA decline📉 & CLEAR➕➡️➖within days to 2-4 weeks. Unprecedented! 📆March is #ColorectalCancerAwarenessMonth https://t.co/zQSWQUMFxH https://t.co/8lqv95s0A3